Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms

Oncogene

Volumn 18, Issue 24, 1999, Pages 3564-3573

  Elliott, Katherine ^a   Sakamuro, Daitoku ^a   Basu, Amithaba ^a   Du, Wei ^a   Wunner, William ^a   Staller, Peter ^b   Gaubatz, Stefan ^b   Zhang, Hong ^c   Prochownik, Edward ^c   Eilers, Martin ^b   Prendergast, George C ^a  

^a WISTAR INSTITUTE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

c Myc; Transcription; Transformation; Tumor supressor

Indexed keywords

ORNITHINE DECARBOXYLASE;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRUS E1A PROTEINS; ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NUCLEAR PROTEINS; ORNITHINE DECARBOXYLASE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); REPRESSOR PROTEINS; RESPONSE ELEMENTS; SEQUENCE DELETION; SRC HOMOLOGY DOMAINS; THYMOSIN; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ADENOVIRIDAE;

EID: 0033577992     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202670     Document Type: Article

References (50)

1. Ayer DE, Lawrence QA and Eisenman RN. (1995). Cell, 80, 767-776.
2. Bauer F, Urdaci M, Aigle M and Crouzet M. (1993). Mol. Cell. Biol., 13, 5070-5084.
3. Beijersbergen RL, Hijmans EM, Zhu I. and Bernards R. (1994). EMBO J., 13, 4080-4086.
4. Bello-Fernandez C, Packham G and Cleveland JL. (1993). Proc. Natl. Acad. Sci. USA, 90, 7804-7808.
5. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG, Miller SC and Webster C. (1985). Science, 230, 758-766.
6. Chen C and Okayama H. (1987). Mol. Cell Biol., 7, 2745-2752.
7. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB and Jensen RH. (1996). Cancer Res., 56, 3091-3102.
8. Desbarats L, Gaubatz S and Eilers M. (1996). EMBO J., 10, 447-460.
9. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nat. Genet., 4, 42-46.
10. Dyson N and Harlow E. (1992). Cancer Surv., 12, 161-195.
11. Eilers M, Schirm S and Bishop M. (1991). EMBO J., 10, 133-141.
12. Evan GI, Lewis GK, Ramsay G and Bishop JM. (1985). Mol. Cell Biol., 5, 3610-3616.
13. Facchini LM and Penn LZ. (1998). FASEB J., 12, 633-651.
14. GU W, Bhatia K, Magrath IT, Dang CV and DallaFavera R. (1994). Science, 264, 251-254.
15. Gupta S, Seth A and Davis RJ. (1993). Proc. Natl. Acad. Sci. USA, 90, 3216-3220.
16. Hann SR, Abrams HD, Rohrschneider LR and Eisenman RN. (1983). Cell, 34, 789-798.
17. Hansen R, Reddel R and Braithwaite A. (1995). Oncogene, 11, 2535-2545.
18. Harlow E and Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY.
19. Hateboer G, Timmers H, Rustgi AK, Billaud M, Van'tVeer LJ and Bernards R. (1993). Proc. Natl. Acad. Sci. USA, 90, 8489-8493.
20. Henriksson M and Lüscher B. (1996). Adv. Canc. Res., 68, 109-182.
21. Hulboy DL and Lozano G. (1994). Cell Growth Diff., 5, 1023-1031.
22. Kadlee L and Pendergast A-M. (1997). Proc. Natl. Acad. Sci. USA, 94, 12390-12395.
23. Kato GJ, Barrett J, Villa-Garcia M and Dang CV. (1990). Mol. Cell. Biol., 10, 5914-5920.
24. Kelekar A and Cole M. (1986). Mol. Cell. Biol., 6, 7-14.
25. Kretzner L, Blackwood EM and Eisenman RN. (1992). Curr Top. Microbiol. Immunol., 182, 435-443.
26. Land H, Parada LF and Weinberg RA. (1983). Nature, 304, 596-602.
27. Lupas A. (1996). Meth. Enz., 266, 513-525.
28. Maruyama K, Schiavi SC, Huse W, Johnson GL and Ruley HE. (1987). Oncogene, 1, 361-367.
29. Michalovitz D, Halevy O and Oren M. (1990). Cell, 62, 671-681.
30. Negorev D, Reithman H, Wechsler-Reya R, Sakamuro D, Prendergast GC and Simon D. (1996). Genomics, 33, 329-331.
31. O'Reilly DR, Miller LK and Luckow VA. (1992). In: Baculovirus expression vectors: a laboratory manual. WH Freeman and Co., Inc., New York.
32. Packham G and Cleveland JL. (1997). Oncogene, 15, 1219-1232.
33. Phelps WC, Yee CL, Munger K and Howley PM. (1988). Cell, 53, 539-547.
34. Prendergast GC. (1997). In: Oncogenes as Transcriptional Regulators. Yaniv M and Ghysdael J. (eds). Birkhauser Verlag: Boston, pp. 1-28.
35. Prendergast GC, Hopewell R, Gorham B and Ziff EB. (1992). Genes Dev., 6, 2429-2439.
36. Prendergast GC, Lawe D and Ziff EB. (1991). Cell, 65, 395-407.
37. Prendergast GC and Ziff EB. (1991). EMBO J., 10, 757-766.
38. Ramjaun AR and McPherson PS. (1998). J. Neurochem., 70, 2369-2376.
39. Ruley HE. (1983). Nature, 304, 602-606.
40. Sakamuro D, Elliott K, Wechsler-Reya R and Prendergast GC. (1996). Nature Genet., 14, 69-77.
41. Sakamuro D, Sabbatini P, White E and Prendergast GC. (1997). Oncogene, 15, 887-898.
42. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI and De Pinho RA. (1995). Cell, 80, 777-786.
43. Walker KK and Levine AJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 15335-15340.
44. Wechsler-Reya R, Elliott K, Herlyn M and Prendergast GC. (1997a). Cancer Res., 57, 3258-3263.
45. Wechsler-Reya R, Elliott K and Prendergast GC. (1998). Mol. Cell. Biol., 18, 566-575.
46. Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J and Prendergast GC. (1997b). J. Biol. Chem., 272, 31453-31458.
47. Wigge P and McMahon HT. (1998). Trends Neurosci., 21, 339-344.
48. Yuan ZM, Huang Y, Fan MM, Sawyers C, Kharbanda S and Kufe D. (1996). J. Biol. Chem., 271, 26257-26460.
49. Zhang H and Prochownik E. (1997). J. Biol. Chem., 272, 17416-17424.
50. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N and Harlow E. (1993). Genes Dev., 7, 1111-1125.